The Guangdong Provincial Medical Products Administration and Health Commission jointly released , on 2 December, the 2024 catalogue of Hong Kong and Macao-registered drugs and medical devices for urgent clinical use in the nine mainland cities of the Greater Bay Area (GBA).

The National Medical Products Administration recently released interim provisions on the administration of “domestic responsible persons” designated by foreign marketing authorisation holders (MAHs). The provisions, which will take effect on 1 July 2025 specify the qualifications that must be possessed by such persons and the requirements for foreign MAHs in reporting drug imports.

Foreign and domestic food and medical device facilities – including any Hong Kong or mainland Chinese facilities – that do not properly renew their registrations with the FDA can be locked out of the U.S. market. Renewals for both types of facilities are due by the end of this year.

The growing role played by advanced technology in ageing societies was prominently on display at the AGE-WELL conference in Edmonton.

Tackling the challenges and learning the lessons of ageing societies globally was high on the agenda at Canada’s AGE-WELL event.

Many attendees at Seoul’s HIMSS APAC expo had one eye on expanding into other Asian markets, with Hong Kong quite firmly in their sights.

Helping the elderly treat their long-term ailments at home was the aim of many of the high-tech exhibits at this year’s Houston Abilities Expo.

Ensuring senior citizens can remain active community members was the central concern of many exhibitors at the Houston Abilities Expo.

While growing affluence got a mention, most Pharmed & Healthcare Vietnam exhibitors cited market size as prompting their participation.

Market size, rising healthcare spending and a shift to more elderly demographic buoyed attendance at the Pharmed & Healthcare Vietnam event.